Created at	Source	Raw Value	Validated value
Jan. 21, 2022, noon	usa	Immunogenicity of neutralizing antibody (GMT);Incidence of Adverse Event within 28 days post the second study intervention	Immunogenicity of neutralizing antibody (GMT);Incidence of Adverse Event within 28 days post the second study intervention